Circular RNA circEXOC6B Inhibits the Progression of Ovarian Cancer by Sponging miR-421 and Regulating RUS1 Expression

被引:18
作者
Wang, Zhonghai [1 ]
Zhang, Wenmin [2 ]
Fang, Jinchuan [2 ]
Xie, Ping [2 ]
Miao, Miao [2 ]
Yang, Hongwen [2 ]
机构
[1] Huazhong Univ Sci & Technol, Dept Gynecol, Shenzhen 518052, Guangdong, Peoples R China
[2] Women & Children Hlth Inst Futian Shenzhen, Shenzhen 518017, Guangdong, Peoples R China
关键词
ovarian cancer; circular RNAs; circEXOC6B; miR-421; TUS1; PROLIFERATION; CELLS;
D O I
10.2147/OTT.S243040
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Evidence has been shown that circular RNAs (circRNAs) play a vital role during the development of ovarian cancer. However, the mechanism by which circEXOC6B regulates tumorigenesis of ovarian cancer remains unknown. Thus, this study aimed to investigate the role of circEXOC6B during the progression of ovarian cancer. Materials and Methods: The dual-luciferase reporter system assay was used to determine the interaction between circEXOC6B, miR-421 and RUS1 in ovarian cancer, respectively. CCK8 and colony formatting were used to evaluate cell proliferation. Meanwhile, the expressions of RSU1, PINCH1 and ILK in SKOV3 cells were detected with Western blot. Results: Downregulation of circEXOC6B markedly promoted the proliferation and invasion in A2780 cells. In contrast, upregulation of circEXOC6B significantly inhibited the proliferation and invasion in SKOV3 cells. Moreover, overexpression of circEXOC6B obviously induced the apoptosis of SKOV3 cells. Furthermore, luciferase reporter assay identified that miR-421 was the potential miRNA binding of circEXOC6B, and RUS1 was the potential binding target of miR-421. Mechanism analysis indicated that upregulation of circEXOC6B increased the level of RUS1 by acting as a competitive "sponge" of miR-421. Conclusion: In this study, we found that circEXOC6B suppressed the growth of ovarian cancer cells through upregulating RSU1 partially via sponging miR-421. Therefore, circEXOC6B might be a potential target for the treatment of ovarian cancer.
引用
收藏
页码:8233 / 8243
页数:11
相关论文
共 33 条
[1]  
[Anonymous], 2006, NAT REV MOL CELL BIO, DOI DOI 10.1038/NRM1789
[2]  
[Anonymous], 2019, AGING US, DOI DOI 10.18632/AGING.102414
[3]  
[Anonymous], 2018, CANCER MANAG RES, DOI DOI 10.2147/CMAR.S16
[4]  
[Anonymous], 2008, EUR J CELL BIOL, DOI DOI 10.1016/J.EJCB.2008.02.011
[5]  
[Anonymous], 2018, INT J ONCOL, DOI DOI 10.3892/IJ0.2018.4566
[6]  
[Anonymous], 2019, CANCER CELL INT
[7]  
[Anonymous], 2019, AM J TRANSL RES
[8]  
[Anonymous], 2019, CANCER MANAG RES, DOI DOI 10.2147/CMAR.S226
[9]  
[Anonymous], 2016, CANCER BIOL MED, DOI DOI 10.20892/J.ISSN.2095-3941.2016.0024
[10]  
[Anonymous], 2019, MOL CANCER, DOI DOI 10.1186/S12943-018-0933-7